Charles River Laboratories International Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $316.9M | $261.6M | $55.3M | $43.6M |
| FY2017 | $318.1M | $235.6M | $82.4M | $44.0M |
| FY2018 | $441.1M | $301.1M | $140.1M | $47.3M |
| FY2019 | $480.9M | $340.4M | $140.5M | $57.3M |
| FY2020 | $546.6M | $380.0M | $166.6M | $56.3M |
| FY2021 | $760.8M | $532.0M | $228.8M | $71.5M |
| FY2022 | $619.6M | $294.9M | $324.7M | $73.6M |
| FY2023 | $683.9M | $365.4M | $318.5M | $72.0M |
| FY2024 | $734.6M | $501.6M | $233.0M | $69.9M |
| FY2025 | $737.6M | $518.5M | $219.2M | $71.1M |